ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

SILO Silo Pharma Inc

1.85
0.00 (0.00%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Silo Pharma Inc SILO NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.85 10:00:00
Open Price Low Price High Price Close Price Previous Close
1.85 1.7701 1.85 1.85 1.85
more quote information »

Recent News

Date Time Source Heading
23/4/202422:15GLOBESilo Pharma Announces Positive Results for Intranasal PTSD..
10/4/202422:11GLOBESilo Pharma set to Acquire Exclusive Licensing for Promising..
20/3/202423:30GLOBESilo Pharma Exercises Option for Exclusive License Agreement..
18/3/202422:15GLOBESilo Pharma Files Patent for Groundbreaking Ketamine Implant..
29/2/202400:25GLOBESilo Pharma Completes Successful Dose-Ranging Study of..
15/2/202400:45GLOBESilo Pharma’s SP-26 Ketamine Implant Demonstrates Successful..
02/2/202405:15EDGAR2Form 8-K - Current report
02/2/202402:00GLOBESilo Pharma Announces Pipeline Prioritization for 2024..
31/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
26/1/202409:29EDGAR2Form S-3/A - Registration statement under Securities Act of..
26/1/202409:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202400:55GLOBESilo Pharma Announces Positive Results in Alzheimer’s..
24/1/202409:01EDGAR2Form S-3 - Registration statement under Securities Act of..
12/1/202404:15EDGAR2Form 8-K/A - Current report: [Amend]
10/1/202408:30EDGAR2Form 8-K - Current report
05/1/202400:55GLOBESilo Pharma Successfully Completes First Phase of..
29/12/202300:25GLOBESilo Pharma and Partner Receive Regulatory Approval to Begin..
22/12/202308:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:58EDGAR2Form 8-K12B - Notification that a class of securities of..
19/12/202311:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:05EDGAR2Form 8-K - Current report
08/12/202310:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202308:05EDGAR2Form 8-K - Current report
05/12/202308:55EDGAR2Form 8-K - Current report
01/12/202313:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202309:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202300:01GLOBESilo Pharma Enters into Exclusive License Agreement with..
21/11/202311:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202309:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202300:11GLOBESilo Pharma to Initiate Dose-Ranging Study of Novel..
24/10/202308:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/10/202308:00EDGAR2Form DEF 14A - Other definitive proxy statements
16/10/202323:11GLOBESilo Pharma’s SPU-21 Peptide Shows Positive Results Against..
11/10/202323:35GLOBESilo Pharma Initiates Human Factor Study of SPC-15 for the..
11/10/202307:00EDGAR2Form PRE 14A - Other preliminary proxy statements
20/9/202322:28GLOBESilo Pharma Announces Positive Data on SPC-15 for PTSD and..
12/9/202322:50GLOBESilo Pharma Initiates Feasibility Study of SPC-15 Novel..
31/8/202321:30EDGAR2Form 8-K - Current report
12/8/202306:50EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:50GLOBESilo Pharma Engages Clarivate for Intellectual Property and..
08/8/202322:30GLOBESilo Pharma Reaches Positive Milestone with Nasal..
30/6/202306:31EDGAR2Form 8-K - Current report
21/6/202323:00GLOBESilo Pharma’s SPU-21 Treatment for Autoimmune Disease..
13/6/202322:05GLOBESilo Pharma Signs Agreement to Develop First-in-Class..
02/6/202322:50GLOBESilo Pharma Announces Participation on Webull Corporate..
30/5/202323:00GLOBESilo Pharma Commences Study of Novel Joint Homing Peptide..
09/5/202322:05GLOBESilo Pharma’s SPC-15 Awarded U.S. Patent Protecting Ongoing..

Your Recent History

Delayed Upgrade Clock